Cardioprotective Impact of JAKi, Tofacitinib, on CV Risk in Rheumatoid Arthritis: JAKi CV Risk Impact Study

被引：0
|
作者：
Syngle, Ashit [1 ]
Verma, Inderjeet [2 ]
Garg, Nidhi
Chauhan, Kanchan [1 ]
Patyal, Sapna [1 ]
Syngle, Devaansh [3 ]
机构：
[1] Healing Touch City Clin, Chandigarh, India
[2] Maharishi Markandeshwar Univ, Mulana, India
[3] Healing Touch Fdn, Chandigarh, India
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0448
引用
收藏
页码：868 / 869
页数：2
相关论文
共 50 条
  • [21] IMPACT OF BASELINE CARDIOVASCULAR RISK ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN THE TOFACITINIB RHEUMATOID ARTHRITIS CLINICAL PROGRAMME
    Dougados, M.
    Charles-Schoeman, C.
    Szekanecz, Z.
    Giles, J. T.
    Ytterberg, S. R.
    Bhatt, D. L.
    Koch, G. G.
    Vranic, I.
    Wu, J.
    Wang, C.
    Kwok, K.
    Menon, S.
    Connell, C. A.
    Yndestad, A.
    Rivas, J. L.
    Buch, M. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 175 - 176
  • [22] Modifiable Rheumatoid Arthritis Factors and Impact on Cardiovascular Risk
    Liao, Katherine
    Etzel, Carol J.
    Greenberg, Jeffrey D.
    Guan, Hongshu
    Kremer, Joel
    Solomon, Daniel H.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [23] The Impact of Nutrition on Disease Risk and Course of Rheumatoid Arthritis
    Keysser, G.
    AKTUELLE RHEUMATOLOGIE, 2015, 40 (06) : 449 - 453
  • [24] Carotid artery volumetric measures associate with clinical ten-year cardiovascular (CV) risk scores and individual traditional CV risk factors in rheumatoid arthritis; a carotid-MRI feasibility study
    Lesley-Anne Bissell
    Bara Erhayiem
    Graham Fent
    Elizabeth M. A. Hensor
    Agata Burska
    Helena Donica
    Sven Plein
    Maya H. Buch
    John P. Greenwood
    Jacqueline Andrews
    Arthritis Research & Therapy, 20
  • [25] Carotid artery volumetric measures associate with clinical ten-year cardiovascular (CV) risk scores and individual traditional CV risk factors in rheumatoid arthritis; a carotid-MRI feasibility study
    Bissell, Lesley-Anne
    Erhayiem, Bara
    Fent, Graham
    Hensor, Elizabeth M. A.
    Burska, Agata
    Donica, Helena
    Plein, Sven
    Buch, Maya H.
    Greenwood, John P.
    Andrews, Jacqueline
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [26] EVALUATING THE IMPACT OF METFORMIN TARGETS ON THE RISK OF RHEUMATOID ARTHRITIS: A MENDELIAN RANDOMIZATION STUDY
    Wang, Q.
    Gao, Y.
    Yang, T.
    Qiao, J.
    Zhang, S. X.
    Wang, C.
    Li, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1220 - 1221
  • [27] Analysis of the Impact of Tofacitinib Treatment on Weight in Patients with Rheumatoid Arthritis
    Wollenhaupt, Juergen
    Morel, Jacques
    Daien, Claire
    Ruyssen-Witrand, Adeline
    Lukas, Cedric
    Richez, Christophe
    Shapiro, Andrea
    Chapman, Douglass S.
    Cros, Magali
    Rivas, Jose L.
    Citera, Gustavo
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [28] ANALYSIS OF THE IMPACT OF TOFACITINIB TREATMENT ON WEIGHT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Wollenhaupt, J.
    Morel, J.
    Daien, C.
    Ruyssen-Witrand, A.
    Lukas, C.
    Richez, C.
    Shapiro, A.
    Chapman, D.
    Cros, M.
    Rivas, J. L.
    Citera, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1148 - 1149
  • [29] IMPACT OF ADJUSTING CARDIOVASCULAR RISK SCORES TO KNOWN RISK RATIOS IN RHEUMATOID ARTHRITIS
    Bailey, Kimberley A.
    Kumar, Namita
    RHEUMATOLOGY, 2009, 48 : I130 - I130
  • [30] Risk of Incident Cancer with Biologic and Tofacitinib Therapy in Rheumatoid Arthritis
    England, Bryant R.
    Pedro, Sofia
    Mikuls, Ted R.
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345